ArticleBMC research notes2026
Atrial fibrillation among adults hospitalized with heart failure in Southern Ethiopia: prevalence, predictors, and embolic complications.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine the prevalence, clinical predictors, and embolic complications of atrial fibrillation among adults hospitalized with heart failure in Southern Ethiopia.
resultsAmong 403 adults hospitalized with heart failure (mean age 53.3 ± 18.1 years; 60.5% women), atrial fibrillation was present in 30.5% (95% CI: 26–35%). The most common underlying etiologies were valvular heart disease and dilated cardiomyopathy. Embolic complications occurred in 8.9% of patients, predominantly ischemic stroke; some events were present at admission, limiting causal inference. Independent predictors of atrial fibrillation included age > 60 years, diabetes mellitus, chronic kidney disease, and left atrial enlargement (> 40 mm), whereas hypertension showed an inverse association. Atrial fibrillation was significantly associated with embolic complications. Among patients receiving warfarin, only 31.9% achieved therapeutic anticoagulation, and subtherapeutic anticoagulation was associated with increased embolic risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.